URCN | Unité de Recherche Clinique de NANORO

Switch to desktop Register Login

Publications 2015 (20 articles published)

1

Tinto H, Sevene E, Dellicour S, Calip GS, d’Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, Ter Kuile F, Stergachis A. (2015) Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reproductive Health, 2015 Dec 4;12(1):112. doi:10.1186/s12978-015-0101-0.

 

2

Tinto H, Sombié O, Valea I, Lankoandé F, Yara S, Lompo P, Tahita MC, Kazienga A, Ouédraogo S, Sorgho H, De Crop M, Ravinetto R. (2015). Field evaluation of SD-Bioline malaria antigen P.f® for Plasmodium falciparum malaria diagnosis in Nanoro, Burkina Faso. African Journal of Parasitology research, 4 (11), 161-165.

 

3

Da O, Traoré/Coulibaly M, Ouédraogo JCW, Yaro B, Yerbanga RS, Kini F, Koama B, Dakuyo ZP, Nikiema JB, Ouédraogo GA, Matsabisa MG, Ouédraogo JB. (2015). Phytochemical screening of Saye, a traditional herbal remedy for malaria. International Journal of Biological Sciences and Chemical Sciences; Dec 2015, 9; 6, 2940 – 2946.

 

4

Sondo P, Valea I, Biebo B, Sorgho H, Kazienga A, Ouedraogo J-B, Guiguemdé TR, Tinto H. (2015). La part du paludisme dans les maladies fébriles en saison sèche dans la région de Nanoro, Burkina Faso. West African Medical Journal, Jun 9;21:101. doi: 10.11604/pamj.2015.21.101.6437. eCollection 2015.

 

5

Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, Lievens M, Abdulla S, Adjei S, Agbenyega T, Agnandji ST, Aide P, Anderson S, Ansong D, Aponte JJ, Asante KP, Bejon P, Birkett AJ, Bruls M, Connolly KM, D'Alessandro U, Dobaño C, Gesase S, Greenwood B, Grimsby J, Tinto H, Hamel MJ, Hoffman I, Kamthunzi P, Kariuki S, Kremsner PG, Leach A, Lell B, Lennon NJ, Lusingu J, Marsh K, Martinson F, Molel JT, Moss EL, Njuguna P, Ockenhouse CF, Ogutu BR, Otieno W, Otieno L, Otieno K, Owusu-Agyei S, Park DJ, Pellé K, Robbins D, Russ C, Ryan EM, Sacarlal J, Sogoloff B, Sorgho H, Tanner M, Theander T, Valea I, Volkman SK, Yu Q, Lapierre D, Birren BW, Gilbert PB, Wirth DF. (2015). Genetic diversity and protective efficacy of the RTS,S/AS01 malaria vaccine. New England Journal of Medicine, 2015 (373) 21: 2025-2037. doi:10.1056/NEJMoa1505819.

 

6

White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, Drakeley C, Gesase S, Lusingu J, Ansong D, Adjei S, Agbenyega T, Ogutu B, Otieno L, Otieno W, Agnandji ST, Lell B, Kremsner P, Hoffman I, Martinson F, Kamthunzu P, Tinto H, Valea I, Sorgho H, Oneko M, Otieno K, Hamel MJ, Salim N, Mtoro A, Abdulla S, Aide P, Sacarlal J, Aponte JJ, Njuguna P, Marsh K, Bejon P, Riley EM, Ghani AC. (2015). Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infectious Diseases, 15: 1450–1458. doi:10.1016/S1473-3099(15)00239-X

 

7

Held J, Supan C, Salazar CL, Tinto H, Bonkian LN, Nahum A, Moulero B, Sié A, Coulibaly B, Sirima SB, Siribie M, Otsyula N, Otieno L, Abdallah AM, Kimutai R, Bouyou-Akotet M, Kombila M, Koiwai K, Cantalloube C, Din-Bell C, Djeriou E, Waitumbi J, Mordmüller B, Ter-Minassian D, Lell B, Kremsner PG. (2015). Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Lancet Infectious Diseases, 15: 1409–1419. doi: 10.1016/S1473-3099(15)00079-1

 

8

Sondo P, Derra K, Tarnagda Z, Nakanabo SD, Zampa O, Kazienga A, Valea I, Sorgho H, Ouedraogo JB, Guiguemde TR, Tinto H. (2015). Dynamic of Plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso. Pan African Medical Journal. 2015 Jun 9;21:101. doi: 10.11604/pamj.2015.21.101.6437

 

9

WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group (2015). Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Medicine 2015, 13:212.   doi:10.1186/s12916-015-0445-x.

 

10

Tahita MC, Tinto H, Erhart A, Kazienga A, Fitzhenry R, Van Overmeir C, Rosanas-Urgell A, Ouedraogo JB, Guiguemde RT, Van Geertruyden JP, D'Alessandro U. (2015). Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine. PLoS ONE. 2015 Sep 14;10(9):e0137440. doi:10.1371/journal.pone.0137440.

 

11

Sondo P, Derra K, Diallo-Nakanabo S, Tarnagda Z, Zampa O, Kazienga A, Valea I, Sorgho H, Owusu-Dabo E, Ouedraogo JB, Guiguemde TR, Tinto H. (2015). Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Malaria Journal, Aug 20;14(1):325. doi:10.1186/s12936-015-0843-8.

 

12

RTS,S Clinical Trials Partnership (2015). Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet, 2015 Jul 4;386(9988):31-45. doi:10.1016/S0140-6736(15)60721-8.

 

13

Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. (2015). The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infectious Diseases, 2015 Jun;15(6):692-702. doi:10.1016/S1473-3099(15)70024-1.

 

14

Tahita MC, Tinto H, Yarga S, Kazienga A, Traore/Coulibaly M, Valea I, Van Overmeir C, Rosanas-Urgell A, Ouedraogo JB, Guiguemde RT, van Geertruyden JP, Erhart A, D'Alessandro U. (2015). Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso. Malaria Journal, 2015 Jun 20;14(1):251.   doi:10.1186/s12936-015-0769-1.

 

15

Dakuyo Z, Meda AL, Ollo D, Kiendrebeogo M, Traoré-Coulibaly M, Novak J, Benoit-Vical F, Weisbord E, Willcox M. (2015). SAYE: the story of an antimalarial phytomedicine from Burkina Faso. Journal of Alternative and Complementary Medicine, 2015 Apr;21(4):187-95. doi:10.1089/acm.2014.0147.

 

16

Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, Abdulla S, Owusu-Agyei S, Mulokozi A, Adjei A, Sevene E, Compaoré G, Valea I, Osei I, Yawson A, Adjuik M, Akparibo R, Ogutu B, Upunda GL, Smith P, Binka F. (2015). Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malaria Journal, 2015 Apr 15;14:160. doi: 10.1186/s12936-015-0664-9.

 

17

Tiono AB, Tinto H, Alao MJ, Meremikwu M, Tshefu A, Ogutu B, Ouedraogo A, Lingani M, Cousin M, Lefèvre G, Jain JP, Duparc S, Hamed K. (2015). Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®). Malaria Journal, 2015 Apr 15;14(1):157. doi:10.1186/s12936-015-0682-7.

 

18

Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A. (2015). In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso. Antimicrobial Agents and Chemotherapy. 2015 Jan;59(1):734-7. doi: 10.1128/AAC.03647-14

 

19

Nambozi M, Mulenga M, Halidou T, Tagbor H, Mwapasa V, Phiri LK, Kalanda G, Valea I, Traore M, Mwakazanga D, Claeys Y, Schurmans C, De Crop M, Menten J, Ravinetto R, Thriemer K, Van Geertruyden JP, Mutabingwa T, D'Alessandro U; PregACT Group. (2015). Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial. Reproductive Health, 2015 Jan 15;12:5. doi:10.1186/1742-4755-12-5.

 

20

Ravinetto RM, Afolabi MO, Okebe J, Van Nuil JI, Lutumba P, Mavoko HM, Nahum A, Tinto H, Addissie A, D'Alessandro U, Grietens KP. (2015). Participation in medical research as a resource-seeking strategy in socio-economically vulnerable communities: call for research and action.Tropical Medicine and International Health, 2015 Jan;20(1):63-6. doi:

10.1111/tmi.12396.

 

Copyright 2014 - CRUN | Clinical research Unit of Nanoro. All right reserves.

Top Desktop version